Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-24-019658

← back to feed
Filed
May 15, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 15, 2024 32.63M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $43.86K
Cash And Equivalents Q1 2024 · Dec 31, 2023 $57.29K
Current Liabilities Q1 2024 · Mar 31, 2024 $4.26M
Current Liabilities Q1 2024 · Dec 31, 2023 $4.07M
Total Liabilities Q1 2024 · Mar 31, 2024 $4.49M
Total Liabilities Q1 2024 · Dec 31, 2023 $4.32M
Current Assets Q1 2024 · Mar 31, 2024 $588.18K
Current Assets Q1 2024 · Dec 31, 2023 $584.09K
Total Assets Q1 2024 · Mar 31, 2024 $968.79K
Total Assets Q1 2024 · Dec 31, 2023 $992.3K
Shares Diluted Q1 2024 · Mar 31, 2023 32.53M sh
Operating Cash Flow restated Q1 2024 · Mar 31, 2023 $24.62K
Stockholders Equity Q1 2024 · Mar 31, 2023 −$3.1M
Stockholders Equity Q1 2024 · Dec 31, 2022 −$2.94M
Eps Diluted Q1 2024 · Mar 31, 2023 $0.00
Eps Basic Q1 2024 · Mar 31, 2023 $0.00
Sga Expense Q1 2024 · Mar 31, 2023 $277.1K
Rd Expense Q1 2024 · Mar 31, 2023 $5.51K
Net Income Q1 2024 · Mar 31, 2023 $6.86K
Operating Income Q1 2024 · Mar 31, 2023 $33.21K
Gross Profit Q1 2024 · Mar 31, 2023 $330.2K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $30.8K
Revenue Q1 2024 · Mar 31, 2023 $360.99K